Does myocarditis after SARS-CoV-2 mRNA vaccination have better clinical outcomes compared to myocarditis associated with covid-19 disease and conventional myocarditis?
Myocarditis following SARS-CoV-2 mRNA vaccination has a more favorable 90-day clinical course than conventional or COVID-19-associated myocarditis.
Compared with myocarditis associated with covid-19 disease and conventional myocarditis, myocarditis after vaccination with SARS-CoV-2 mRNA vaccines was associated with better clinical outcomes within 90 days of admission to hospital.
Husby et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: